Business
Phase 2 Trial of CYP-001 in aGvHD Approved in Turkey
Phase 2 Trial of CYP-001 in aGvHD Approved in Turkey
About this update from Cynata Therapeutics Limited
[{"type":"text","content":"Cynata Therapeutics Ltd has released a press release. View Attachment","length":235,"tagName":"div"}]